Research from UCLA and Vanderbilt shows that new melanoma drug nearl..
|
||||||
Research from UCLA and Vanderbilt shows that new melanoma drug nearl..NCI Cancer Center News Research from UCLA and Vanderbilt shows that new melanoma drug nearly doubles survival in majority of patients Investigators from Vanderbilt-Ingram Cancer Center, UCLA and 11 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival Click here to read full press release from Vanderbilt-Ingram Cancer Center. Click here to read full press release from UCLA. ### NCI comprehensive cancer centers logoAmong the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer?s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers? research results are often at the forefront of studies in the cancer field.
|
||||||
Dit is een bericht uit het Nieuwsbank persberichtenarchief. Gegevens in dit bericht kunnen verouderd zijn. Overname is toegestaan onder voorwaarden. Eventueel in dit bericht vermelde (e-mail) adressen en telefoonnummers zijn uitsluitend bedoeld voor journalisten.
comments powered by Disqus |